Home > Boards > US OTC > Cannabis >

Endocan Corp. (ENDO)

ENDO RSS Feed
Add ENDO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/23/2022 7:02:09 PM - Followers: 158 - Board type: Free - Posts Today: 0

About Endocan Corporation

The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.
 

Premium quality of life is one of the most rewarding ways to feel great and outright spoil ourselves. The Endocan product line by The Endocan Corporation is a new stage of
innovative cannabinoid-based solutions, with a fresh focus on the health decisions of today. The critical ailments, such as cancer,AIDS/HIV, asthma, glaucoma, influenza,
pain management, & PTSD to more general conditions, such as sunburn and skin dryness, all seem to have a beneficial response to cannabinoids.
Endocan utilizes the unique and potent benefits of cannabinoids; the natural components found in the cannabis plant.
Cannabinoids are the ideal solution due to their organic properties that the body responds extremely well to. Endogenous endocannabinoid system is responsible for
the unique communication pathways in the brain and body affecting many important functions including modulation of the response to disease. Our formulations
target the endocannabinoid system thus affecting the cause, not only the symptoms. Endocan’s motivation to bring superior products to their respective markets is based on the incredible market need for answers to critical ailments and generalconditions.
The personal care market including   cosmeceuticals, nutraceuticals, and anti-aging is one of the largest in the world.




 

Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.


 

 

 

 

Corporate Overview

"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."

Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.

Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.

Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.

Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.

Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.

Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.

Endocan is poised to flourish in the retailmarket place. Endocan aims to capture a profitable share of the personal care as well as a portion of the critical ailment markets.Endocan diversifies it product base into more product lines and marketing focuses on Endocan becoming more of a household name.
Endocan’s unique formulations matched with Endocan’s unmatched ability to deliver new and exciting products to the market
enhanced by our branding identity is essential to our success. Our formulations include proprietary extracts
that increase the quality, durability, and effectiveness of the products, especially when compared to other consumer options that currently exist on the shelf.
Sales are illustrated to rise to over $100million dollars over five to ten years as the
company benefits from both global expansion and franchising opportunities.


 

                        

           About Cannabis & Cannabinoids

About CannabiinoidsThere are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”

Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:

 

  • Cannabigerols (CBG)
  • Cannabichromenes (CBC)
  • Cannabidiols (CBD)
  • Tetrahydrocannabinols (THC)
  • Cannabinol (CBN) and Cannabinodial (CBDL)
  • Other Cannabinoids

The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”


 

The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.


 

A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.


History of Cannabis

The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.

In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.

The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.

 

     

      

 

Critical Ailments

Endocan develops products for critical ailments.

The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.

Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.

Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:

Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?

Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.


 

Table: Market Analysis


 



Market Analysis Chart


 

Table: Global Potential Customers

Global Potential Customers Chart



Table: Global Potential Customers - Cancer

Global Potential Customers with Cancer Chart



 

     

 


                                                                                        

Corporate Profile

Endocan is dedicated to quality, respect for human life, and constant evaluation.

Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.

Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.

 

Executive Summary

Please click on the document title to download.

Download PDF Document Endocan Corporation 2013 Executive Summary


Endocan Moves Forward With New Product Releases After Successful Brand and Website Launch; Focused Efforts Include Product Distribution Outlets for USA, Canada, and Europe Oct-23-2013
Endocan Corporation (XCHC) is Pleased to Announce the Endocan™ www.endocan.com Website Goes Live Today Oct-17-2013
Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan™ on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding to Bring its Medical Cannabis Formulations to Market as its Next Major Corporate Move Oct-14-2013
Endocan Corporation, FKA The X-Change Corp, Motivated by Canadian Government Move; From Huffington Post: 'Canada Medical Marijuana: Health Canada Presides Over Birth Of Billion-Dollar Free Market' Oct-01-2013
XCHC Changes Corporate Name to "Endocan Corporation"; Medical Cannabis Industry-Driven Branding Campaign Begins with Name Change and Continues into the Arizona Dispensary Opening Sep-26-2013
The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website Sep-06-2013
X-Change Corp. Recaps Significant Corporate Activities for Past 15 Days Sep-05-2013
X-Change Corp. Delighted with DOJ's Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees 'Green Light' for Company's Patient-Driven Medical Cannabis Operations Under State Laws Aug-30-2013
X-Change Moves Forward Signing Next Multi-Year Contracts with State-Licensed Medical Cannabis Dispensary in Arizona to Develop, Dispense, Infuse, and Cultivate Products for On-Site, Use of 'Medbox' Technology for Fulfillment, and Distribution Aug-21-2013
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting Aug-20-2013





Management Team
 

Dr Dorothy Bray, Ph.D.
Director & President
 
Chad S. Johnson, Esq.
Director, COO &General Counsel
 
Mario Lap
Director & President of European Operations
 
Robert Kane
Director, CFO & Sr.VP for Business Development
 
Alfredo Dupetit
Director & VP European Operations
 
Drue Young
Vice President of Product Development

 
Steven B. Hopping, M.D., F.A.C.S.

 
Board of Advisors, Senior Medical Advisor
Greta Gaines

 
Board of Advisors, Marketing Specialist
Greta Gaines

_______________________________________________________________________________________________________________



Company Stock Symbol
XCHC - View Stock Quote


Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001

Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001

Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120
Email: signaturestock@aol.com

http://www.endocan.com/


 

 

ENDO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENDO News: Thermic Science acquires hybrid banking company VIPOnline 12/29/2021 04:38:52 AM
PostSubject
#8986   These two douchebags couldn’t sell weed at a sicofbs 05/23/22 07:02:09 PM
#8985   Looking more like a Gray listing Dean14 05/23/22 04:25:29 PM
#8984   Lol… it left a skid mark I believe sicofbs 05/23/22 01:16:57 PM
#8983   After audits we will be in a strong U ROCK 05/20/22 11:17:07 AM
#8982   Is the dabney / Kane Rickey ship stalled sicofbs 05/17/22 01:51:21 PM
#8981   in·cre·du·li·ty /?inkr?'d(y)o?ol?de/ ?Learn to pronounce noun the state of b U ROCK 05/09/22 09:12:57 AM
#8980   Lol…Raymond c. dabney biggest scammer ever … sicofbs 04/29/22 10:40:44 AM
#8979   What is all this about? I guess we will U ROCK 04/29/22 09:36:44 AM
#8978   Lol… dabney is too busy swindling people to sicofbs 04/28/22 07:01:52 PM
#8977   Maybe you will get your gift shares trading U ROCK 04/21/22 12:15:46 AM
#8976   Alternative reporting what could we see? In longs WallStreetMyWay 04/01/22 03:16:15 PM
#8975   DD things building business takes time? holding these WallStreetMyWay 04/01/22 03:15:01 PM
#8974   Pos stock scamming scumbag like his whole family sicofbs 04/01/22 10:18:01 AM
#8973   The Raymond Dabney truth. Where are my CBIS The Montalian 03/28/22 11:39:48 AM
#8972   Bentley boy has fled the scene or he’s sicofbs 03/28/22 11:28:13 AM
#8971   One, two One, two, three, ow Wake up, kids We got U ROCK 03/21/22 09:52:25 AM
#8970   Can't stop, addicted to the shindig Chop Top, he U ROCK 03/21/22 09:42:51 AM
#8969   Imagine the pos dabney driving around in a sicofbs 03/18/22 12:17:51 PM
#8968   Explain how that matter to endo holders sicofbs 03/16/22 11:00:50 AM
#8967   https://www.benzinga.com/markets/cannabis/22/02/25146835/73-of-chronic-pain-pati U ROCK 02/28/22 02:28:01 PM
#8966   It's funny how I find myself in love U ROCK 02/26/22 08:27:58 AM
#8965   It's funny how I find myself in love U ROCK 02/26/22 08:25:57 AM
#8964   Time, why you punish me? Like a wave crashing U ROCK 02/22/22 08:01:19 AM
#8963   Yeah but this isn’t part of that sicofbs 01/26/22 01:00:18 PM
#8962   Why? Cannabis cures cancer? Cannabis cures covid? Cannabis cures? They knew U ROCK 01/21/22 11:09:19 AM
#8961   After a decade … lol.. Bentley never sold sicofbs 01/18/22 01:05:43 PM
#8960   https://madamenoire.com/1305755/cannabis-could-block-covid-19/ The Tree of Life U ROCK 01/16/22 03:58:55 PM
#8959   https://www.wsls.com/news/2022/01/12/hemp-compounds-prevent-covid-19-from-enteri U ROCK 01/13/22 10:47:17 PM
#8958   Lol… this is the best Bentley guy can sicofbs 01/03/22 12:20:17 PM
#8957   This is quite the rant… Raymond C. Dabney 2 weeks Portuguese Ham 01/03/22 11:16:19 AM
#8956   The scam continues. PH, I'm sorry to say The capCaptain 12/30/21 12:36:15 PM
#8955   More news coming, loading zone trader_ron 12/30/21 12:34:43 PM
#8954   Can't see the light Can't see the U ROCK 12/27/21 01:10:40 AM
#8953   Dabney ….Probably dumping just enough everyday to keep sicofbs 12/22/21 05:43:10 PM
#8952   Is the lying pos ceo still sicofbs 12/18/21 08:03:21 AM
#8951   Looks like the Bentley douche is still dumping sicofbs 12/13/21 10:42:34 AM
#8950   I think it means... What's good for the goose U ROCK 12/01/21 10:14:10 PM
#8949   It’s all BS …. Paint and pot Harvard sicofbs 11/30/21 12:56:32 PM
#8948   Again, I am asking for someone to break Portuguese Ham 11/30/21 12:31:27 PM
#8947   Lol… if ten years of cbis fraud failure sicofbs 11/30/21 12:18:14 PM
#8946   Again… not helpful and does not answer my Portuguese Ham 11/30/21 12:06:26 PM
#8945   Perhaps history will answer tour questions … go sicofbs 11/30/21 11:34:35 AM
#8944   None of that was helpful, but thank you. Portuguese Ham 11/29/21 12:50:31 PM
#8943   Dabneys issued these reports full of lies and sicofbs 11/29/21 11:17:25 AM
#8942   Can someone break this down and what it Portuguese Ham 11/28/21 07:14:34 PM
#8941   $ENDO Thermic Science Prepares Form 10 Registration Statement AskMuncher 11/28/21 10:47:04 AM
#8940   $ENDO Thermic Science Prepares Form 10 Registration Statement AskMuncher 11/28/21 10:43:44 AM
#8939   Lol… nothings changed … nothing worth the paper sicofbs 11/24/21 02:14:17 PM
#8938   I wonder what this means for the bag Portuguese Ham 11/18/21 10:43:47 AM
#8937   $ENDO AskMuncher 11/18/21 08:04:43 AM
PostSubject
Consent Preferences